https://salarnews.in/public/uploads/images/advertisment/1734528783_header_adds.gif

Oppn flays Congress govt over healthcare tragedies

R Ashoka, the Leader of the Opposition, said while the government promotes financial assistance schemes like Gruha Lakshmi, the public is increasingly concerned about maternal mortality rates

PTI

https://salarnews.in/public/uploads/images/newsimages/maannewsimage06122024_222158_health.JPG
  • Representative Picture

BENGALURU, 6 DEC

 

The recent maternal deaths at the Ballari Medical College and Research Centre (BMCRC) have drawn sharp criticism from the Opposition in Karnataka. R Ashoka, the Leader of the Opposition, slammed the ruling Congress government for failing to ensure the safety of patients. He pointed out that while the government promotes financial assistance schemes like Gruha Lakshmi, the public is increasingly concerned about maternal mortality rates.

 

Ashoka stated, “Women are saying they don’t want Rs 2,000—they want justice.” His condemnation highlights a growing dissatisfaction within the community regarding the handling of healthcare issues and the perceived negligence by government authorities. He asserted that the people of Karnataka rightfully demand accountability for these tragic incidents.

 

The Health Minister, Dinesh Gundu Rao, emphasised the importance of a thorough investigation, promising that anyone found responsible will face consequences.

 

He highlighted that the health department had written to the Central Drugs Standard Control Organisation (CDSCO) questioning why it was certifying drugs "rejected by Karnataka".

 

"You approve drugs that we reject. What are we supposed to do next? We can’t blacklist the company or reject their products outright because they might then approach the court claiming their product is safe. What should be the next step, and who is responsible for this?" Rao questioned, stressing the need for a "third-party review of drugs."

 

Rao added that a team of officers had inspected the West Bengal-based drug manufacturer Panschim Banga’s facility and was directed to submit a report.

 

"They have inspected because we need to prosecute the drug manufacturer. We are moving forward with legal action," he said. -PTI

Leave a Reply

Your email address will not be published. Required fields are marked *